01 September 2001
Prospects for treatment of HIV1 viral infections
Patryk SmolińskiCase Rep Clin Pract Rev 2001; 2(4):295-304 :: ID: 475351
Abstract
The latest revelation of the HIV1 natural history infection has made more aspects of the virus entry into cells more comprehensible. It is described as a multistage process with a key role of receptors and coreceptors. Succeeding binding of the structures launches a conformational casacade leading to virus-cell membrane fusion. Isolation of particles effectively blocking the process could enable creating new classes of antiretroviral drugs with a completely different way of affecting the virus. Certain prototype structures have already resulted to be successful - mostly according to in vitro research. However, further studies concerning in vivo analysis-which has partly been pursued-seems to be very promising, as well.
Keywords: HIV1, AIDS, fusion, Chemokines
SARS-CoV-2/COVID-19
19 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936370
17 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936651
13 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936589
13 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936574
In Press
23 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.935148
23 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936704
23 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936600
20 May 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936826
Most Viewed Current Articles
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
17 Feb 2022 : Case report
DOI :10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
19 Feb 2022 : Case report
DOI :10.12659/AJCR.935355
Am J Case Rep 2022; 23:e935355